H Tsubouchi Selected Research

H Tsubouchi Research Topics

Disease

6	Hepatocellular Carcinoma (Hepatoma) 03/2004 - 01/2000
4	Infections 01/2002 - 08/2000
4	Neoplasms (Cancer) 10/2001 - 01/2000
3	Chronic Hepatitis C 02/2012 - 08/2000
3	Liver Diseases (Liver Disease) 06/2001 - 01/2000
2	Liver Neoplasms (Liver Cancer) 01/2005 - 01/2000
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Eczema 01/2022
1	Heartburn (Pyrosis) 06/2014
1	Osteoporosis 01/2014
1	Bone Resorption 01/2014
1	Thrombosis (Thrombus) 03/2011
1	Sclerosing Cholangitis 03/2011
1	Type 2 Diabetes Mellitus (MODY) 03/2009
1	Pre-Eclampsia (Preeclampsia) 12/2006
1	Diabetic Nephropathies (Diabetic Nephropathy) 09/2005
1	Hepatitis C 01/2005
1	Diabetic Angiopathies (Diabetic Angiopathy) 09/2003
1	Persistent Infection 01/2002
1	Carcinogenesis 06/2001
1	Carcinoma (Carcinomatosis) 06/2001
1	Body Weight (Weight, Body) 06/2001
1	Granuloma 06/2001
1	Hepatitis B 06/2001
1	Acute Liver Failure (Fulminant Hepatic Failure) 06/2001
1	Hypoxia (Hypoxemia) 04/2001
1	Community-Acquired Infections 04/2001
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2001
1	Tics (Tic) 12/2000
1	Hyperthermia 12/2000
1	Adenocarcinoma 12/2000
1	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2000
1	Dermatomyositis (Dermatopolymyositis) 09/2000
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2000
1	Chronic Thyroiditis 08/2000
1	Ulcerative Colitis 07/2000
1	Neurologic Manifestations (Neurological Manifestations) 06/2000
1	Mixed Connective Tissue Disease (MCTD) 06/2000
1	Neutropenia 05/2000
1	Dumping Syndrome (Syndrome, Dumping) 05/2000

Drug/Important Bio-Agent (IBA)

3	Messenger RNA (mRNA)IBA 12/2006 - 01/2000
3	RNA (Ribonucleic Acid)IBA 01/2005 - 11/2001
3	DNA (Deoxyribonucleic Acid)IBA 06/2001 - 08/2000
2	Proteins (Proteins, Gene)FDA Link 12/2006 - 11/2001
2	InterferonsIBA 03/2004 - 08/2000
2	EnzymesIBA 01/2002 - 10/2000
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022
1	Ointments (Pastes)IBA 01/2022
1	Phosphodiesterase 4 InhibitorsIBA 01/2022
1	difamilastIBA 01/2022
1	CytokinesIBA 01/2022
1	AcidsIBA 06/2014
1	odanacatibIBA 01/2014
1	Cathepsin KIBA 01/2014
1	telaprevirIBA 02/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 02/2012
1	Glucose (Dextrose)FDA LinkGeneric 03/2009
1	Sitagliptin Phosphate (Januvia)FDA Link 03/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2005
1	AntigensIBA 01/2005
1	NADPH Oxidases (NAD(P)H oxidase)IBA 09/2003
1	Alanine Transaminase (SGPT)IBA 01/2002
1	HGF activatorIBA 11/2001
1	CyclinsIBA 06/2001
1	Cyclin D1IBA 06/2001
1	Peptides (Polypeptides)IBA 06/2001
1	EpitopesIBA 06/2001
1	EndotoxinsIBA 06/2001
1	Etoposide (VP 16)FDA LinkGeneric 06/2001
1	GalactosamineIBA 06/2001
1	LipopolysaccharidesIBA 06/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2001
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2001
1	ElementsIBA 04/2001
1	Thymidine KinaseIBA 04/2001
1	Ganciclovir (Cytovene)FDA LinkGeneric 04/2001
1	MART-1 AntigenIBA 02/2001
1	BromidesIBA 12/2000
1	Fluorouracil (Carac)FDA LinkGeneric 12/2000
1	Immunoglobulin G (IgG)IBA 10/2000
1	ImmunosorbentsIBA 10/2000
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2000
1	Intravenous Immunoglobulins (IVIG)FDA Link 09/2000
1	AutoantibodiesIBA 08/2000
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 08/2000
1	Insulin ReceptorIBA 08/2000
1	SteroidsIBA 07/2000
1	Mesalamine (Mesalazine)FDA LinkGeneric 07/2000
1	Prednisolone (Predate)FDA LinkGeneric 06/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2000
1	Copper Sulfate (Sulfate, Copper)FDA Link 05/2000
1	CopperIBA 05/2000

Therapy/Procedure

5	Therapeutics 03/2004 - 06/2000
1	Transplantation 03/2011
1	Liver Transplantation 03/2011
1	Drug Therapy (Chemotherapy) 12/2000
1	Radiotherapy 12/2000
1	Enema (Enemas) 07/2000